NDC11 71894020001
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71894-0200-01 | 71894-0200 |
| 71894-0200-1 | 71894-0200 |
| 71894-200-01 | 71894-200 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ITVISMA | ONASEMNOGENE ABEPARVOVEC-BRVE | Novartis Innovative Technologies Inc. | ab2e1c6c-4f95-4243-9296-1734e0a30591 | 2026-06-16 | Boxed warning, Warnings, Adverse reactions | 71894-200-01 71894-200 71894020001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.